Sign in
NYXH Stock Price, Chart, Stats & News
Nyxoah S.A.
Save
Nyxoah S.A. (NYXH) does not currently pay a dividend.
61.00M
Market cap
–
Current P/E
–
Forward P/E
NYXH chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 63.13% |
Operating margin | -844.36% |
Pretax margin | -889.09% |
Net margin | -899.14% |
Effective tax rate | -1.13% |
ROA | -76.06% |
ROE | -135.30% |
D/E | 0.86x |
Interest coverage ratio | -16.15x |
NYXH valuation
P/E | – |
P/S | 9.11x |
P/B | 2.00x |
P/CF | -1.44x |
P/FCF | -1.30x |
P/OCF | -1.44x |
PEG | 0.22x |
EV multiple | -0.98x |
About
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Similar securities
Based on sector and market capitalization
Report issue